Correspondence regarding a published study: Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials

被引：0
|
作者：
Zhang, Cheng [1 ]
Merdler, Ilan [1 ]
Waksman, Ron [1 ,2 ]
机构：
[1] MedStar Washington Hosp Ctr, Sect Intervent Cardiol, Washington, DC USA
[2] MedStar Washington Hosp Ctr, 110 Irving St,NW,Suite 4B-1, Washington, DC 20010 USA
来源：
CARDIOVASCULAR REVASCULARIZATION MEDICINE | 2023年 / 57卷
关键词：
D O I：
10.1016/j.carrev.2023.07.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 49 条
  • [41] Glucose-insulin-potassium infusion in patients with acute myocardial infarction treated with Reperfusion therapy does not reduce the risk of cardiovascular events: A pooled meta-analysis of randomized controlled trials
    Katragadda, Srikanth
    Saha, Sandeep A.
    Arora, Rohit R.
    CIRCULATION, 2007, 116 (16) : 849 - 849
  • [42] Association of polyunsaturated fatty acids with improved heart rate variability and cardiovascular events in patients with end-stage renal disease receiving maintenance dialysis: a systematic review and meta-analysis of randomized controlled trials
    Chou, Chu-Lin
    Chen, Jin-Shuen
    Kang, Yi-No
    Chen, Yuan-Jen
    Fang, Te-Chao
    FOOD & FUNCTION, 2021, 12 (17) : 8090 - 8099
  • [43] Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study
    Itoh, Hiroshi
    Komuro, Issei
    Takeuchi, Masahiro
    Akasaka, Takashi
    Daida, Hiroyuki
    Egashira, Yoshiki
    Fujita, Hideo
    Higaki, Jitsuo
    Hirata, Ken-ichi
    Ishibashi, Shun
    Isshiki, Takaaki
    Ito, Sadayoshi
    Kashiwagi, Atsunori
    Kato, Satoshi
    Kitagawa, Kazuo
    Kitakaze, Masafumi
    Kitazono, Takanari
    Kurabayashi, Masahiko
    Miyauchi, Katsumi
    Murakami, Tomoaki
    Murohara, Toyoaki
    Node, Koichi
    Ogawa, Susumu
    Saito, Yoshihiko
    Seino, Yoshihiko
    Shigeeda, Takashi
    Shindo, Shunya
    Sugawara, Masahiro
    Sugiyama, Seigo
    Terauchi, Yasuo
    Tsutsui, Hiroyuki
    Ueshima, Kenji
    Utsunomiya, Kazunori
    Yamagishi, Masakazu
    Yamazaki, Tsutomu
    Yo, Shoei
    Yokote, Koutaro
    Yoshida, Kiyoshi
    Yoshimura, Michihiro
    Yoshimura, Nagahisa
    Nakao, Kazuwa
    Nagai, Ryozo
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 791 - 800
  • [44] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials
    Boehm, Michael
    Baumhaekel, Magnus
    Teo, Koon
    Sleight, Peter
    Probstfield, Jeffrey
    Gao, Peggy
    Mann, Johannes F.
    Diaz, Rafael
    Dagenais, Gilles R.
    Jennings, Garry L. R.
    Liu, Lisheng
    Jansky, Petr
    Yusuf, Salim
    CIRCULATION, 2010, 121 (12) : 1439 - U114
  • [45] Association of obstructive sleep apnea with cardiovascular events in acute coronary syndrome patients with dual risk of remnant cholesterol and low-grade inflammation: a post-hoc analysis of the OSA-ACS study
    Xu, Ding
    Zhang, Yuekun
    Zhen, Lei
    Hao, Wen
    Zheng, Wen
    Yan, Yan
    Wang, Xiao
    Nie, Shaoping
    SLEEP AND BREATHING, 2025, 29 (01)
  • [46] Impact of Smoking on Cardiovascular Events in Patients With Established Coronary Disease Receiving Contemporary Medical Therapy: a Post Hoc Analysis of the Treating to New Targets (TNT) & the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Trials
    Frey, Paul F.
    Waters, David D.
    DeMicco, David A.
    Breazna, Andrei
    Samuels, Larry
    Pipe, Andrew L.
    Benowitz, Neal L.
    CIRCULATION, 2010, 122 (21)
  • [47] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCEND) Trials Editorial Comment
    Seftel, Allen
    JOURNAL OF UROLOGY, 2010, 184 (04): : 1454 - 1455
  • [48] PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
    Wu, Zhi-Ming
    Kan, Jing
    Ye, Fei
    You, Wei
    Wu, Xiang-Qi
    Tian, Nai-Liang
    Lin, Song
    Ge, Zhen
    Liu, Zhi-Zhong
    Li, Xiao-Bo
    Gao, Xiao-Fei
    Chen, Jing
    Wang, Yan
    Wen, Shang-Yu
    Xie, Ping
    Cong, Hong-Liang
    Liu, Li-Jun
    Zeng, He-Song
    Zhou, Lei
    Liu, Fan
    Zheng, Yong-Hong
    Li, Rui
    Ji, Hong-Lei
    Zhou, Sheng-Hua
    Zhao, Shou-Ming
    Qian, Xue-Song
    Luo, Jun
    Wang, Xin
    Zhang, Jun-Jie
    Chen, Shao-Liang
    AMERICAN HEART JOURNAL, 2024, 277 : 58 - 65
  • [49] Heart Protection Study (HPS), Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), and Treatment of HDL (High-Density Lipoprotein) to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Collaborative Groups. Assessment of vascular event prevention and cognitive function among older adults with preexisting vascular disease or diabetes: a secondary analysis of 3 randomized clinical trials (vol 2, e190223, 2019)
    Offer, A.
    Arnold, M.
    Clarke, R.
    JAMA NETWORK OPEN, 2019, 2 (03)
12345